Videos

 

May 4, 2016 - Mr. Zurik’s initial report centered on PBM clawbacks, exposing how certain PBMs charge patients a co-pay that is higher than the drugs actual costs. Of course, due to restrictions in their contract, the pharmacist can do nothing to inform the patient of the lower-cost cash price available to them unless specifically asked by the patient. The subject of this article tie in directly with LIPA-sponsored Senate Bill 131, which would allow pharmacists to begin telling patients if their medication would be cheaper to buy without insurance, a practice currently forbidden by most PBM contracts. Part 1→

 

Videos

September 21, 2016 - The Clarence Buggs Show

Clarence Buggs Show Segment 9-21-16